Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0QU8H
|
|||
| Former ID |
DPR000002
|
|||
| Drug Name |
(S)-amisulpride
|
|||
| Synonyms |
UNII-ES3TWM82E8; ES3TWM82E8; 71675-92-8; Amisulpride, (S)-; AC1MHORM; SCHEMBL675545; NTJOBXMMWNYJFB-LBPRGKRZSA-N; ZINC1846088; Benzamide, 4-amino-N-(((2S)-1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxy-; LS-25533; UNII-8110R61I4U component NTJOBXMMWNYJFB-LBPRGKRZSA-N; 4-amino-N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]-5-ethylsulfonyl-2-methoxybenzamide
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Schizophrenia [ICD-11: 6A20] | Discontinued in Phase 4 | [1] | |
| Company |
Sanofi-Aventis
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H27N3O4S
|
|||
| Canonical SMILES |
CCN1CCCC1CNC(=O)C2=CC(=C(C=C2OC)N)S(=O)(=O)CC
|
|||
| InChI |
1S/C17H27N3O4S/c1-4-20-8-6-7-12(20)11-19-17(21)13-9-16(25(22,23)5-2)14(18)10-15(13)24-3/h9-10,12H,4-8,11,18H2,1-3H3,(H,19,21)/t12-/m0/s1
|
|||
| InChIKey |
NTJOBXMMWNYJFB-LBPRGKRZSA-N
|
|||
| CAS Number |
CAS 71675-92-8
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
825251, 834618, 7885684, 7888168, 10299511, 12012879, 14964694, 26702476, 36887324, 46391424, 46393315, 49689717, 49853891, 50752736, 57404612, 81062582, 87544180, 92729723, 99437067, 103023822, 103585278, 104038074, 104631735, 123121432, 124757133, 125083567, 125163937, 134338965, 134339490, 135692087, 136368136, 144115532, 144205150, 162023511, 162037530, 170464784, 172386359, 175269637, 175611917, 176484930, 177748581, 178103397, 179116541, 210279189, 210281512, 223984695, 226406984, 241376066, 250133961, 252156703
|
|||
| SuperDrug ATC ID |
N05AL05
|
|||
| SuperDrug CAS ID |
cas=071675859
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | The pipeline and future of drug development in schizophrenia. Mol Psychiatry. 2007 Oct;12(10):904-22. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.